Clinical Drug Investigation

Show Articles
Journal Properties
  • Formerly known as
    Drug Investigation
  • Country
    United Kingdom
  • Language
    English
  • Number of Articles
    3,811
  • Abbreviation
    Clin Drug Investig
  • ISSN
    1173-2563
  • e-ISSN
    1179-1918
  • Main Publisher
    Springer Nature
  • Publisher
    Springer Science and Business Media LLC
  • Indian UGC
  • Indian UGC Name
  • DOAJ (latest)
Journal Properties
  • Medicine
    Public aspects of medicine
    Toxicology
    Poisons
    Medicine
    Therapeutics
    Pharmacology
  • website
Description
Clinical Drug Investigation is an international journal focusing on the clinical development and investigation of new and established drugs. It provides a platform for publishing original research, reviews, and short communications related to all phases of clinical trials, from early-stage studies to post-marketing surveillance. The journal aims to advance the understanding of drug efficacy, safety, and optimal use in various patient populations. Key areas covered include clinical pharmacology, pharmacokinetics, pharmacodynamics, drug interactions, and therapeutic outcomes. Clinical Drug Investigation is indexed in databases such as Scopus, Web of Science, and Embase, ensuring wide dissemination of its scholarly content. It targets clinicians, researchers, pharmaceutical scientists, and regulatory professionals involved in drug development and clinical practice. Clinical Drug Investigation aims to improve patient care by providing timely and relevant information on drug therapy. The journal welcomes submissions that contribute to the optimization of drug development processes, the identification of new therapeutic targets, and the enhancement of clinical outcomes for patients worldwide.